Andrew D. Goldberg

Insider Reports History

Location
Irvine, CA
Signature
/s/ Scott Sieckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew D. Goldberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director Common Stock 16.7K $791K $47.36 13 Jun 2025 Direct
Tarsus Pharmaceuticals, Inc. Director Stock Option (right to buy) 4.54K $55K $10.99 12 Jun 2025 Direct
Tarsus Pharmaceuticals, Inc. Director Restricted Stock Units 0 $0 $27.47 13 Jun 2025 Direct

Insider Reports Filed by Andrew D. Goldberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 12 Jun 2025 4 $0 4 Director 16 Jun 2025, 16:04
TARS Tarsus Pharmaceuticals, Inc. 07 Mar 2025 2 $90.2K 4 Director 11 Mar 2025, 16:01
TARS Tarsus Pharmaceuticals, Inc. 24 Jun 2024 2 $0 4 Director 25 Jun 2024, 18:26
TARS Tarsus Pharmaceuticals, Inc. 13 Jun 2024 2 $0 4 Director 14 Jun 2024, 17:45
TARS Tarsus Pharmaceuticals, Inc. 15 Dec 2023 1 $19K 4 Director 19 Dec 2023, 18:30
TARS Tarsus Pharmaceuticals, Inc. 22 Jun 2023 2 $0 4 Director 26 Jun 2023, 17:56
TARS Tarsus Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 18:18
TARS Tarsus Pharmaceuticals, Inc. 16 Jun 2022 2 $0 4 Director 01 Jul 2022, 12:21
TARS Tarsus Pharmaceuticals, Inc. 15 Jun 2021 2 $0 4 Director 17 Jun 2021, 19:21